Product Description
CK-8 Polyclonal Antibody | E-AB-40213 | Elabscience
Type: Polyclonal Antibody
Synonyms: CARD2, CK 8, CK-8, CK8, CYK8, CYKER, Cytokeratin endo A, Cytokeratin-8, DreK8, EndoA, K2C8, K2C8, K8, Keratin 8, Keratin type II cytoskeletal 8, Keratin, type II cytoskeletal 8, Keratin-8, KO, Krt 2.8, KRT8, MGC118110, MGC174782, MGC53564, MGC85764, sb:cb186, Type-II keratin Kb8
Application: WB, IHC
Reactivity: Human, Mouse
Host: Rabbit
Isotype: IgG
Reserch Areas: Cancer, Signal Transduction
Background: Cytokeratin 8 (CK8) has a molecular weight of 52.5 KDa, which belongs to the HMW (high molecular weight) B-type Cytokeratin. CK8 is mainly marked on non-squamous epithelium, thus can be used for the diagnosis of adenocarcinoma and ductal carcinoma. Generally, CK8 is not expressed in squamous cell carcinoma. It is reported that hepatocellular carcinoma mainly express CK8 and CK18.
Concentration: 2 mg/mL
Storage: Store at -20°C. Avoid freeze / thaw cycles.
Immunogen: Recombinant Human Keratin, type II cytoskeletal 8 protien
Buffer: PBS with 0.05% Proclin300 and 50% glycerol, pH7.4.
Purification Method: Affinity Purification
Dilution: WB 1:500-1:1000 IHC 1:100-1:400
Clone: N/A
Conjugation: Unconjugated
Molecular Weight(Calculated): 54, 57 kDa
Molecular Weight(Observed): 57 kDa